Company Overview
- Headquarters
- 700 Park Offices Drive, Suite 200, Durham NC
- Website
- g1therapeutics.com
- Phone
- (919) 213-9835
- Employees
- 112
- Founded in
- 2008
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:GTH
- NAICS Code
-
NAICS Code 325 CompaniesNAICS Code 54 CompaniesNAICS Code 32 CompaniesNAICS Code 5413 CompaniesNAICS Code 54138 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$24B
Total Funding Amount
$206M
Who is G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage oncology company headquartered in Research Triangle Park, North Carolina. The company employs 112 people and generated $24.2 million in revenue. G1 Therapeutics focuses on developing and commercializing next-generation anti-cancer therapies. Their product portfolio includes COSELA® (trilaciclib), a commercially available product, and a pipeline of targeted cancer therapies in various stages of development. These therapies are being evaluated for use in treating a range of solid tumors, including breast, lung, and bladder cancers. The company is driven by a team with extensive expertise in cancer biology, development, and commercialization. Their mission is to improve the lives of cancer patients through innovative therapies. For more information about G1 Therapeutics and its products, visit www.g1therapeutics.com. You can also follow the company on Twitter @G1Therapeutics.
Company Leadership
G1 Therapeutics Industry Tags
G1 Therapeutics Tech Stack
Companies Similar to G1 Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to G1 Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
24M | 27 | Wilmington, DE | 1998 | |
24M | 6 | Doylestown, PA | 2010 | |
24M | 115 | Williams, OR | 1979 | |
24M | 229 | Emeryville, CA | 2013 | |
23M | 220 | San Diego, CA | 2014 |